Profile data is unavailable for this security.
About the company
Qingdao NovelBeam Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of medical endoscopic equipment and optical products. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)413.02m
- Net income in CNY124.91m
- Incorporated2003
- Employees797.00
- LocationQingdao NovelBeam Technology Co LtdNo.100 Keyuanwei 4th RoadLaoshan DistrictQINGDAO 266100ChinaCHN
- Phone+86 53 288706015
- Fax+86 53 288705263
- Websitehttps://www.novelbeam.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWS Hemodialysis Care Co Ltd | 532.45m | 74.82m | 4.49bn | 881.00 | 59.99 | 2.66 | -- | 8.44 | 0.233 | 0.233 | 1.66 | 5.27 | 0.2759 | 1.86 | 4.66 | 604,373.60 | 3.72 | -- | 4.02 | -- | 46.37 | -- | 13.47 | -- | 10.93 | -- | 0.016 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Getein Biotech Inc | 1.25bn | 252.99m | 4.53bn | 2.14k | 17.92 | 1.75 | -- | 3.63 | 0.4988 | 0.4988 | 2.46 | 5.12 | 0.3241 | 1.62 | 2.91 | 584,007.90 | 6.73 | 13.25 | 9.86 | 18.45 | 67.64 | 65.57 | 20.76 | 28.13 | 1.69 | -- | 0.205 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
| Sino Medical Sciences Technology Inc | 417.13m | -4.63m | 4.68bn | 652.00 | -- | 5.46 | -- | 11.23 | -0.0112 | -0.0112 | 1.01 | 2.07 | 0.3498 | 1.45 | 33.50 | 639,765.50 | -0.3445 | -4.21 | -0.411 | -4.71 | 60.22 | 70.96 | -0.985 | -15.76 | 1.61 | -- | 0.1327 | -- | 77.99 | -2.04 | 75.59 | -- | -7.30 | -- |
| Qingdao NovelBeam Technology Co Ltd | 413.02m | 124.91m | 4.72bn | 797.00 | 37.71 | 3.68 | -- | 11.43 | 1.04 | 1.04 | 3.44 | 10.63 | 0.2962 | 0.8663 | 4.68 | 518,221.70 | 8.81 | 14.67 | 9.37 | 16.63 | 63.85 | 62.32 | 29.73 | 34.15 | 9.12 | -- | 0.0262 | 33.55 | -1.31 | 18.58 | -20.19 | 21.71 | 10.45 | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 394.84m | -170.68m | 4.76bn | 684.00 | -- | 1.45 | -- | 12.07 | -2.91 | -2.91 | 6.74 | 58.00 | 0.097 | 0.9747 | 2.52 | 577,244.10 | -4.19 | 25.41 | -4.74 | 31.26 | 65.70 | 63.37 | -43.23 | 32.86 | 4.96 | -- | 0.0903 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| TINAVI Medical Technologies Co Ltd | 168.49m | -160.48m | 4.99bn | 339.00 | -- | 4.23 | -- | 29.61 | -0.3585 | -0.3585 | 0.3756 | 2.62 | 0.1075 | 1.48 | 4.73 | 475,961.90 | -10.24 | -7.86 | -11.04 | -9.07 | 68.66 | 73.58 | -95.24 | -50.09 | 2.21 | -- | 0.1532 | -- | 34.48 | 10.63 | -41.42 | -- | 51.87 | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 1.10bn | 162.27m | 5.03bn | 1.67k | 30.98 | 3.02 | -- | 4.58 | 1.03 | 1.03 | 6.95 | 10.57 | 0.5684 | 6.55 | 4.33 | 656,174.20 | 8.40 | 16.35 | 9.71 | 19.26 | 32.48 | 41.19 | 14.77 | 21.62 | 3.00 | -- | 0.0521 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
| Beijing Chunlizhengda Mdicl Instr Co Ltd | 924.65m | 158.35m | 5.09bn | 1.23k | 36.88 | 2.06 | -- | 5.50 | 0.4078 | 0.4078 | 2.41 | 7.29 | 0.2698 | 0.5381 | 2.15 | 751,138.90 | 4.62 | 12.53 | 5.49 | 15.43 | 71.08 | 72.76 | 17.12 | 26.89 | 3.80 | -- | 0.0003 | 21.63 | 0.5759 | 19.40 | -9.72 | 21.33 | -8.60 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2024 | 8.05m | 10.70% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 5.35m | 7.11% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 2.43m | 3.23% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.79m | 2.38% |
| New China Fund Management Co., Ltd.as of 30 Jun 2024 | 1.73m | 2.30% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2024 | 808.78k | 1.08% |
| JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2024 | 551.97k | 0.73% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 521.99k | 0.69% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2024 | 459.37k | 0.61% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 363.44k | 0.48% |
